Table 2.
Cochrane Collaboration's tool for assessing risk of bias for the 17 identified RCTs.
| Studies | Random sequence | Allocation concealment | Blinding of participants and personnel | Blinding of outcome assessment | Incomplete outcome data | Selective reporting | Other bias | Overall risk of bias |
|---|---|---|---|---|---|---|---|---|
| Aarab et al. [26] | Low | Low | Low | Unclear | Low | Low | Unclear | Low risk |
| Andrén et al. [25] | Low | Low | Unclear | Low | Low | Unclear | Unclear | Low risk |
| Banhiran et al. [19] | High | High | High | High | Low | Low | Unclear | High risk |
| Barnes et al. [27] | Low | High | High | High | Low | Unclear | Unclear | High risk |
| Benoist et al. [28] | Low | Unclear | High | High | Unclear | Low | Unclear | High risk |
| Gagnadoux et al. [29] | High | High | High | High | Unclear | Unclear | Unclear | High risk |
| Gagnadoux et al. [30] | Low | High | High | High | Unclear | Low | Unclear | High risk |
| Ghazal et al. [31] | Low | High | High | High | Unclear | Unclear | Unclear | High risk |
| Gotsopoulos et al. [32] | Unclear | Unclear | Low | High | High | High | Unclear | High risk |
| Hoekema et al. [33] | Low | High | Unclear | Unclear | Low | Low | Unclear | High risk |
| Lam et al. [20] | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear risk |
| Maguire et al. [21] | Low | Low | Unclear | Unclear | High | Unclear | Unclear | Unclear risk |
| Marklund et al. [34] | Low | Unclear | Low | High | High | High | Unclear | High risk |
| Phillips et al. [35] | Unclear | Unclear | Unclear | Unclear | Low | Low | Unclear | Unclear risk |
| Quinnel et al. [22] | Low | Unclear | High | Unclear | High | High | Unclear | High risk |
| Tegelberg et al. [23] | Low | Low | Unclear | Unclear | Low | Unclear | Unclear | Unclear risk |
| Wilhelmsson et al. [24] | Low | Low | Unclear | Unclear | Low | Unclear | Unclear | Unclear risk |